A standard practice in statistical hypothesis testing is to mention the P -value alongside the accept/reject decision. We show the advantages of mentioning an e-value instead. With P -values, it is not clear how to use an extreme observation (e.g. P ≪ α ) for getting better frequentist decisions. With e-values it is straightforward, since they provide Type-I risk control in a generalized Neyman–Pearson setting with the decision task (a general loss function) determined post hoc, after observation of the data—thereby providing a handle on “roving α ’s.” When Type-II risks are taken into consideration, the only admissible decision rules in the post hoc setting turn out to be e-value-based. Similarly, if the loss incurred when specifying a faulty confidence interval is not fixed in advance, standard confidence intervals and distributions may fail, whereas e-confidence sets and e-posteriors still provide valid risk guarantees. Sufficiently powerful e-values have by now been developed for a range of classical testing problems. We discuss the main challenges for wider development and deployment.
No takes yet. Share an insight, caveat, or question.
Peter Grünwald (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: